Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (121) 121
science & technology (103) 103
life sciences & biomedicine (102) 102
male (52) 52
octreotide - analogs & derivatives (52) 52
female (51) 51
radiology, nuclear medicine & medical imaging (50) 50
biological and medical sciences (47) 47
medical sciences (43) 43
middle aged (43) 43
octreotide - therapeutic use (43) 43
tumors (42) 42
aged (37) 37
adult (34) 34
neuroendocrine tumors - radiotherapy (32) 32
radiopharmaceuticals - therapeutic use (32) 32
radionuclide imaging (31) 31
endocrinology & metabolism (30) 30
oncology (30) 30
somatostatin (29) 29
somatostatin - analogs & derivatives (28) 28
treatment outcome (26) 26
neuroendocrine tumors - diagnostic imaging (23) 23
animals (22) 22
receptors, somatostatin - metabolism (22) 22
organometallic compounds - therapeutic use (21) 21
peptides (21) 21
nuclear medicine (18) 18
pancreatic neoplasms - radiotherapy (18) 18
enets guidelines (17) 17
peptide receptor radionuclide therapy (17) 17
indium radioisotopes (16) 16
medicin och hälsovetenskap (16) 16
medicine & public health (16) 16
neuroendocrine tumors - diagnosis (16) 16
neuroendocrine tumors - drug therapy (15) 15
neuroendocrine tumors - therapy (14) 14
octreotide - adverse effects (14) 14
receptors, somatostatin - analysis (14) 14
somatostatin - therapeutic use (14) 14
aged, 80 and over (13) 13
cancer (13) 13
fundamental and applied biological sciences. psychology (13) 13
imaging / radiology (13) 13
investigative techniques, diagnostic techniques (13) 13
medical and health sciences (13) 13
neuroendocrine tumors (13) 13
octreotide (13) 13
pancreatic neoplasms - diagnostic imaging (13) 13
pentetic acid - analogs & derivatives (13) 13
cardiology (12) 12
neuroendocrine tumors - metabolism (12) 12
neuroendocrine tumors - pathology (12) 12
orthopedics (12) 12
prrt (12) 12
radioisotopes - therapeutic use (12) 12
radionuclide investigations (12) 12
vertebrates: endocrinology (12) 12
neuroendocrine tumor (11) 11
organometallic compounds - adverse effects (11) 11
pancreatic neoplasms - drug therapy (11) 11
radiopharmaceuticals - pharmacokinetics (11) 11
receptors, peptide - metabolism (11) 11
yttrium radioisotopes - therapeutic use (11) 11
endocrinopathies (10) 10
further section (10) 10
metastasis (10) 10
pancreatic neoplasms - pathology (10) 10
radioisotopes (10) 10
rats (10) 10
somatostatin receptor (10) 10
tissue distribution (10) 10
care and treatment (9) 9
neurosciences (9) 9
pancreatic neoplasms - diagnosis (9) 9
pancreatic neoplasms - therapy (9) 9
radiation therapy (9) 9
radionuclide therapy (9) 9
radiopharmaceuticals (9) 9
stomach neoplasms - radiotherapy (9) 9
tomography, emission-computed, single-photon (9) 9
antineoplastic agents - therapeutic use (8) 8
carcinoma - therapy (8) 8
gastrointestinal neoplasms - radiotherapy (8) 8
indium radioisotopes - therapeutic use (8) 8
neuroendocrine tumors - mortality (8) 8
octreotate (8) 8
radiopharmaceuticals - adverse effects (8) 8
retrospective studies (8) 8
rezeptor (8) 8
toxicity (8) 8
tyr (8) 8
abridged index medicus (7) 7
carcinoid (7) 7
carcinoma (7) 7
diagnosis (7) 7
diagnostic imaging (7) 7
gastrointestinal neoplasms - diagnostic imaging (7) 7
neoplasms - radiotherapy (7) 7
neuroendocrine tumour (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Recommendations for management of patients with neuroendocrine liver metastases
by Frilling, Andrea, Prof and Modlin, Irvin M, Prof and Kidd, Mark, PhD and Russell, Christopher, Prof and Breitenstein, Stefan, MD and Salem, Riad, Prof and Kwekkeboom, Dik, MD and Lau, Wan-yee, Prof and Klersy, Catherine, MD and Vilgrain, Valerie, Prof and Davidson, Brian, Prof and Siegler, Mark, Prof and Caplin, Martyn, Prof and Solcia, Enrico, Prof and Schilsky, Richard, Prof and for the Working Group on Neuroendocrine Liver Metastases and Working Group Neuroendocrine Liver and Working Group on Neuroendocrine Liver Metastases
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 1, pp. e8 - e21
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Neuroendocrine Tumors - pathology | Biopsy | Neuroendocrine Tumors - secondary | Humans | Neoplastic Cells, Circulating | Liver Neoplasms - pathology | Neoadjuvant Therapy | Liver Neoplasms - therapy | Neuroendocrine Tumors - therapy | Liver Neoplasms - secondary | Hepatectomy | Strategic planning (Business) | Care and treatment | Ablation (Surgery) | Metastasis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Long-term efficacy, survival, and safety of [177Lu-DOTA0,Tyr3]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors
by Brabander, Tessa and Van Der Zwan, Wouter A and Teunissen, Jaap J.M and Kam, Boen L.R and Feelders, Richard A and De Herder, Wouter W and Van Eijck, Casper H.J and Franssen, Gaston J.H and Krenning, Eric P and Kwekkeboom, Dik J
Clinical cancer research, ISSN 1078-0432, 08/2017, Volume 23, Issue 16, pp. 4617 - 4624
Life Sciences & Biomedicine | Oncology | Science & Technology | Outcome Assessment (Health Care) - methods | Humans | Middle Aged | Male | Intestinal Neoplasms - radiotherapy | Leukemia - etiology | Time Factors | Aged, 80 and over | Organometallic Compounds - therapeutic use | Adult | Female | Stomach Neoplasms - radiotherapy | Acute Disease | Octreotide - analogs & derivatives | Organometallic Compounds - adverse effects | Kaplan-Meier Estimate | Octreotide - adverse effects | Pancreatic Neoplasms - radiotherapy | Treatment Outcome | Octreotide - therapeutic use | Myelodysplastic Syndromes - etiology | Neuroendocrine Tumors - radiotherapy | Bronchial Neoplasms - radiotherapy | Outcome Assessment (Health Care) - statistics & numerical data | Aged | Radiopharmaceuticals - adverse effects | Radiopharmaceuticals - therapeutic use | Therapy | Membranes | Effectiveness | Kidneys | Toxicity | Leukemia | Radioisotopes | Cell membranes | Survival | Patients | Lutetium | Myelodysplastic syndrome | Metastases | Confidence intervals | Receptors | Experimental design | Safety engineering | Renal failure | Somatostatin | Safety | Somatostatin receptors | Tumors | Cancer | Neuroendocrine tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text The peripheral blood compartment in patients with Graves' disease: Activated T lymphocytes and increased transitional and pre-naive mature B lymphocytes
by Weerd, Kim and Hagen, Martin and Schrijver, Benjamin and Kwekkeboom, Dirk Jan and Herder, Wouter and Broek, M.R.J and Postema, Pieter and Dongen, Jacques and Staal, Frank and Dik, Willem
Clinical and experimental immunology, ISSN 0009-9104, 11/2013, Volume 174, Issue 2, pp. 256 - 264
T lymphocytes | B lymphocytes | Graves' disease | Life Sciences & Biomedicine | Immunology | Science & Technology | Cell Proliferation | Lymphocyte Activation | Humans | Middle Aged | Immunophenotyping | Male | Lymphocyte Subsets - immunology | Antigens, CD - metabolism | Young Adult | Lymphoid Progenitor Cells - immunology | Graves Disease - immunology | Adult | Female | Immunologic Memory | T-Lymphocytes - immunology | Cell Differentiation | Blood Circulation - immunology | HLA-DR Antigens - metabolism | T cells | Index Medicus | Autoimmune diseases | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Pazopanib: a new drug for pancreatic neuroendocrine tumours
by Kwekkeboom, Dik J
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 6, pp. 606 - 607
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Pancreatic Neoplasms - drug therapy | Pyrimidines - administration & dosage | Carcinoid Tumor - drug therapy | Humans | Neoplasm Recurrence, Local - drug therapy | Neuroendocrine Tumors - drug therapy | Female | Male | Sulfonamides - administration & dosage | Angiogenesis inhibitors | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors
by Bodei, Lisa and Bodei, Lisa and Kidd, Mark and Kidd, Mark and Paganelli, Giovanni and Paganelli, Giovanni and Grana, Chiara M and Grana, Chiara M and Drozdov, Ignat and Drozdov, Ignat and Cremonesi, Marta and Cremonesi, Marta and Lepensky, Christopher and Lepensky, Christopher and Kwekkeboom, Dik J and Kwekkeboom, Dik J and Baum, Richard P and Baum, Richard P and Krenning, Eric P and Krenning, Eric P and Modlin, Irvin M and Modlin, Irvin M
European journal of nuclear medicine and molecular imaging, ISSN 1619-7070, 1/2015, Volume 42, Issue 1, pp. 5 - 19
PRRT | Medicine & Public Health | Orthopedics | Oncology | Bone marrow toxicity | Nuclear Medicine | Imaging / Radiology | Cardiology | NET | Nephrotoxicity | Decision tree analysis | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Humans | Middle Aged | Male | Leukemia, Myeloid, Acute - etiology | Neuroendocrine Tumors - diagnosis | Lutetium - administration & dosage | Yttrium Radioisotopes - administration & dosage | Aged, 80 and over | Adult | Female | Lutetium - therapeutic use | Octreotide - administration & dosage | Child | Yttrium Radioisotopes - therapeutic use | Lutetium - adverse effects | Yttrium Radioisotopes - adverse effects | Octreotide - adverse effects | Radiation Dosage | Octreotide - therapeutic use | Myelodysplastic Syndromes - etiology | Radiopharmaceuticals - administration & dosage | Neuroendocrine Tumors - radiotherapy | Adolescent | Aged | Radiopharmaceuticals - adverse effects | Radiopharmaceuticals - therapeutic use | Receptors, Peptide - metabolism | Hypertension | Hemoglobin | Leukemia | Clinical trials | Neurology | Peptides | Neurons | Endocrine system | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Radiopeptides for imaging and therapy: A radiant future
by Chatalic, Kristell and Kwekkeboom, Dik and Jong, Marion
The Journal of nuclear medicine (1978), ISSN 0161-5505, 12/2015, Volume 56, Issue 12, pp. 1809 - 1812
Radionuclide therapy | Radiopeptides | Perspectives | Developments | Imaging | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Radiopharmaceuticals - pharmacokinetics | Humans | Peptides - pharmacokinetics | Tomography, Emission-Computed, Single-Photon | Molecular Imaging - methods | Positron-Emission Tomography | Neoplasms - diagnostic imaging | Radionuclide Imaging - trends | Neoplasms - therapy | Molecular Imaging - trends | Radionuclide Imaging - methods | Gallium Radioisotopes | Receptors, Somatostatin - antagonists & inhibitors | Receptors, Somatostatin - metabolism | Fluorine Radioisotopes | Nuclear medicine | Medical imaging | Peptides | Medical diagnosis | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Consensus on biomarkers for neuroendocrine tumour disease
by Oberg, Kjell, Prof and Modlin, Irvin M, Prof and De Herder, Wouter, Prof and Pavel, Marianne, Prof and Klimstra, David, Prof and Frilling, Andrea, Prof and Metz, David C, Prof and Heaney, Anthony, MD and Kwekkeboom, Dik, MD and Strosberg, Jonathan, MD and Meyer, Timothy, Prof and Moss, Steven F, Prof and Washington, Kay, Prof and Wolin, Edward, Prof and Liu, Eric, MD and Goldenring, James, Prof
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 9, pp. e435 - e446
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Biomarkers, Tumor - blood | Neuroendocrine Tumors - pathology | Neuroendocrine Tumors - blood | Delphi Technique | Prognosis | United States | Humans | Neoplastic Cells, Circulating | National Cancer Institute (U.S.) | MicroRNAs - blood | Neuroendocrine Tumors - genetics | Biological markers | Medical colleges | Tumors | Metastasis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
by Dik J. Kwekkeboom and Wouter W. de Herder and Boen L. Kam and Casper H. van Eijck and Martijn van Essen and Peter P. Kooij and Richard A. Feelders and Maarten O. van Aken and Eric P. Krenning
Journal of clinical oncology, ISSN 0732-183X, 05/2008, Volume 26, Issue 13, pp. 2124 - 2130
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Gastrointestinal Neoplasms - mortality | Humans | Middle Aged | Male | Gastrointestinal Neoplasms - pathology | Time Factors | Myelodysplastic Syndromes - chemically induced | Neuroendocrine Tumors - diagnostic imaging | Aged, 80 and over | Organometallic Compounds - therapeutic use | Adult | Female | Pancreatic Neoplasms - mortality | Neuroendocrine Tumors - pathology | Severity of Illness Index | Hematologic Diseases - chemically induced | Octreotide - analogs & derivatives | Risk Assessment | Organometallic Compounds - adverse effects | Pancreatic Neoplasms - pathology | Proportional Hazards Models | Carcinoid Tumor - diagnostic imaging | Octreotide - adverse effects | Logistic Models | Treatment Outcome | Octreotide - therapeutic use | Carcinoid Tumor - pathology | Disease-Free Survival | Gastrointestinal Neoplasms - diagnostic imaging | Neuroendocrine Tumors - mortality | Radionuclide Imaging | Aged | Chemical and Drug Induced Liver Injury | Radiopharmaceuticals - adverse effects | Carcinoid Tumor - mortality | Pancreatic Neoplasms - diagnostic imaging | Radiopharmaceuticals - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Neuroendocrine tumours: The role of imaging for diagnosis and therapy
by Van Essen, Martijn and Sundin, Anders and Krenning, Eric P and Kwekkeboom, Dik J
Nature reviews. Endocrinology, ISSN 1759-5029, 02/2014, Volume 10, Issue 2, pp. 102 - 114
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Pancreatic Neoplasms - diagnosis | Humans | Tomography, Emission-Computed, Single-Photon | Tomography, X-Ray Computed | Treatment Outcome | Neuroendocrine Tumors - diagnosis | Positron-Emission Tomography | Diagnostic Imaging - methods | Pancreatic Neoplasms - drug therapy | Magnetic Resonance Imaging | Neuroendocrine Tumors - drug therapy | Intestinal Neoplasms - diagnosis | Radiopharmaceuticals | Intestinal Neoplasms - drug therapy | CT imaging | Health aspects | Usage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
by Kwekkeboom, Dik J and Kam, Boen L and van Essen, Martijn and Teunissen, Jaap J M and van Eijck, Casper H J and Valkema, Roelf and de Jong, Marion and de Herder, Wouter W and Krenning, Eric P
Endocrine-related cancer, ISSN 1351-0088, 3/2010, Volume 17, Issue 1, pp. R53 - R73
Review | Oncology | Endocrinology & Metabolism | Life Sciences & Biomedicine | Science & Technology | Humans | Digestive System Neoplasms - radiotherapy | Antineoplastic Agents - therapeutic use | Yttrium Radioisotopes - pharmacokinetics | Octreotide - pharmacokinetics | Digestive System Neoplasms - drug therapy | Gallium Radioisotopes - therapeutic use | Digestive System Neoplasms - diagnostic imaging | Neuroendocrine Tumors - diagnostic imaging | Receptors, Somatostatin - analysis | Organometallic Compounds - therapeutic use | Yttrium Radioisotopes - therapeutic use | Somatostatin - analogs & derivatives | Radiopharmaceuticals - pharmacokinetics | Octreotide - analogs & derivatives | Organometallic Compounds - pharmacokinetics | Treatment Outcome | Clinical Trials as Topic | Combined Modality Therapy | Indium Radioisotopes - pharmacokinetics | Positron-Emission Tomography - methods | Octreotide - therapeutic use | Somatostatin - pharmacokinetics | Peptides, Cyclic - pharmacokinetics | Neuroendocrine Tumors - radiotherapy | Animals | Organotechnetium Compounds - pharmacokinetics | Positron-Emission Tomography - standards | Receptors, Somatostatin - drug effects | Gallium Radioisotopes - pharmacokinetics | Neuroendo